8@eight: ASX set for dreary start to week

8@eight: ASX set for dreary start to week


It comes as no surprise, really, with the lion's share of activity centring around the embattled financial sector. Bank stocks underpinned the rally on the ASX on Friday, led by CBA, in signs that the market believed the sector's recent trend lower was overdone.



from Biotech News
Share:

Krystal Biotech (KRYS) and Brainstorm Cell Therapeutics (BCLI) Head to Head Comparison

Krystal Biotech (KRYS) and Brainstorm Cell Therapeutics (BCLI) Head to Head Comparison


Krystal Biotech and Brainstorm Cell Therapeutics are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability. 23.1% of Krystal Biotech shares are held by institutional investors.



from Biotech News
Share:

$13.23 Million in Sales Expected for Lexicon Pharmaceuticals, Inc. (LXRX) This Quarter

$13.23 Million in Sales Expected for Lexicon Pharmaceuticals, Inc. (LXRX) This Quarter


Equities research analysts expect that Lexicon Pharmaceuticals, Inc. will announce sales of $13.23 million for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Lexicon Pharmaceuticals' earnings, with the lowest sales estimate coming in at $11.60 million and the highest estimate coming in at $16.37 million.



from Biotech News
Share:

Sanofi SA (SNY) Stake Lessened by Bank of New York Mellon Corp

Sanofi SA (SNY) Stake Lessened by Bank of New York Mellon Corp


Bank of New York Mellon Corp reduced its stake in shares of Sanofi SA by 11.3% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 197,551 shares of the company's stock after selling 25,218 shares during the quarter.



from Biotech News
Share:

Brokerages Expect Intec Pharma (NTEC) to Post -$0.29 Earnings Per Share

Brokerages Expect Intec Pharma (NTEC) to Post -$0.29 Earnings Per Share


Wall Street brokerages expect Intec Pharma to announce earnings per share of for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Intec Pharma's earnings, with the highest EPS estimate coming in at and the lowest estimate coming in at .



from Biotech News
Share:

ImmunoGen, Inc. (IMGN) Shares Sold by Russell Investments Group Ltd.

ImmunoGen, Inc. (IMGN) Shares Sold by Russell Investments Group Ltd.


Russell Investments Group Ltd. lessened its holdings in shares of ImmunoGen, Inc. by 8.0% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 145,115 shares of the biotechnology company's stock after selling 12,557 shares during the period.



from Biotech News
Share:

UB receives A 1.78 million to find new therapies for treating heart failure and diabetes

UB receives A 1.78 million to find new therapies for treating heart failure and diabetes


The University of Birmingham has been awarded 1.78 million by the Wellcome Trust for research aimed at finding new therapies to treat diseases such as heart failure, diabetes and neurodegenerative disorders. The Wellcome Trust Senior Research Fellowship funding has been awarded to Davide Calebiro, Professor of Molecular Endocrinology at the University of Birmingham's Institute of Metabolism and Systems Research and principal investigator at the Centre of Membrane Proteins and Receptors at the Universities of Birmingham and Nottingham.



from Biotech News
Share:

Walgreens to pay $34.5M to settle SEC charges it misled investors on financial targets

Walgreens to pay $34.5M to settle SEC charges it misled investors on financial targets


This June 4, 2014, file photo, shows a Walgreens retail store in Boston. Shares of AmerisourceBergen are soaring before the opening bell, Tuesday, Feb. 13, 2018, on reports that Walgreens is pursuing a complete takeover of the huge drug distributor.



from Biotech News
Share:

Third Circuit Holds That Buyer's Remorse Is Insufficient To Establish Economic Injury

Third Circuit Holds That Buyer's Remorse Is Insufficient To Establish Economic Injury


This month the Third Circuit issued a decision shedding light on an issue facing many courts today: does an individual have standing to sue on the grounds that she purchased a product that, in other contexts has been found to potentially cause cancer, when the plaintiff has not actually suffered any injury other than an alleged economic injury of purchase regret? Estrada v. Johnson & Johnson , No.



from Biotech News
Share:

Bausch Health unit moves to settle charges it misled investors -SEC

Bausch Health unit moves to settle charges it misled investors -SEC


Salix Pharmaceuticals, a unit of Bausch Health Companies Inc , has moved to settle charges brought by the U.S. Securities and Exchange Commission that it misled investors about the company's prospects, the SEC said on Friday. FILE PHOTO: The seal of the U.S. Securities and Exchange Commission hangs on the wall at SEC headquarters in Washington, U.S., June 24, 2011.



from Biotech News
Share:

Medicaid paid drug-maker in Scott's portfolio hundreds of millions

Medicaid paid drug-maker in Scott's portfolio hundreds of millions


Exactly how much Florida Medicaid has paid Gilead for its hepatitis C and HIV drugs is literally a state secret: Beyond a federally required 23 percent rebate, additional cost breaks are exempt from state and federal public records laws. Gov. Rick Scott and his wife Ann have drawn profits of at least $250,000 - and as much as $2.1 million - from a drug company whose sky-high prices are draining state Medicaid coffers.



from Biotech News
Share:

Novo Nordisk to cut 250 jobs in the United States

Novo Nordisk to cut 250 jobs in the United States


Denmark's Novo Nordisk will cut around 250 jobs in the United States, a spokesman told Reuters on Friday. He said it would also hire some new staff in other positions but that the company did not know the number of new positions yet.



from Biotech News
Share:

Us Fda approves Lilly migraine drug; price same as rivals

Us Fda approves Lilly migraine drug; price same as rivals


NEW YORK: Eli Lilly and Co on Thursday said the U.S. Food and Drug Administration approved its migraine drug Emgality, marking the third approval from a promising new class of treatments for the often debilitating headaches. Lilly said it plans to sell the drug, known chemically as galcanezumab, at a list price of US$6,900 a year, or US$575 month.



from Biotech News
Share:

Cuba, US to establish historic biotech joint venture

Cuba, US to establish historic biotech joint venture


Havana, Sep 27 : Cuba and the US will establish a historic biotech joint venture based in Havana to develop new cancer treatments, official sources said. The Cuban-American biotechnology company: Innovative Immunotherapy Alliance S.A., will be based in the Mariel Special Development Zone, some 50 km west of the Cuban capital, Xinhua news agency quoted the sources as saying on Wednesday.



from Biotech News
Share:

BIO Applauds House Passage of the American Innovation Act

BIO Applauds House Passage of the American Innovation Act


Sep 27, 2018--The Biotechnology Innovation Organization today applauded the House of Representatives for passing the American Innovation Act of 2018 , which includes a provision that would protect investments in start-ups from inadvertently triggering the net operating loss limitations under Section 382 of the tax code. R&D-intensive biotech start-ups frequently accumulate substantial NOLs in their early, pre-revenue years, given their typical reliance on investor capital for more than a decade before realizing any product revenue.



from Biotech News
Share:

UK biotech raises bumper $2 billion, despite Brexit blues

UK biotech raises bumper $2 billion, despite Brexit blues


Britain's biotechnology industry has raised a bumper 1.56 billion pounds in the first eight months of this year, surpassing the 1.2 billion reached in the whole of 2017, despite anxiety in the sector about the fallout from Brexit. The increase has been fueled by recent changes to venture capital tax incentives, according to UK BioIndustry Association CEO Steve Bates, as well as global investor enthusiasm for drug discoveries emanating from biotech labs.



from Biotech News
Share:

Finanzen: Huk24 : Huk24 Kfz-Versicherung

Die Huk24 ist eine Tochtergesellschaft der Huk-Coburg. Die Direktversicherung bietet preiswerte Autopolicen an.

from Finanztip Feed
Supported by Video Collection
Share:

Biotech Company MouSensor Closes Seed Round with $3.3 Million

Biotech Company MouSensor Closes Seed Round with $3.3 Million


Biotechnology company MouSensor, Inc., has raised $3.3 million in its seed round, which was co-led by imec.xpand and Alexandria Venture Investments and in participation with New York Ventures and Elma Hawkins, Ph.D. MouSensor develops a platform that digitizes smell, providing objective means to measure odors . Its core technology was developed by co-founders Paul Feinstein, Ph.D., and Charlotte d'Hulst, Ph.D., at the Feinstein Lab for Neurogenetics at Hunter College of the City University of New York.



from Biotech News
Share:

The Best Way to Profit from the $7 Trillion Global Healthcare Industry

The Best Way to Profit from the $7 Trillion Global Healthcare Industry


Across the country, Bernie Sanders acolytes are rising in Congressional and gubernatorial races. As a result, experts believe the pressures from left-leaning groups could turn the 2020 election into a referendum on universal healthcare in the United States.



from Biotech News
Share:

Verständnis der Antibiotikaresistenz bei Patienten mit Mukoviszidose

Verständnis der Antibiotikaresistenz bei Patienten mit Mukoviszidose


image description
Bei Patienten mit Mukoviszidose (CF) bildet sich durch ein defektes Gen dicker, klebriger Schleim in der Lunge. Dort fängt es Bakterien ein und verursacht bei den Patienten häufige Lungeninfektionen, die diese lebenswichtigen Organe nach und nach schädigen und die Atmungsfähigkeit der Patienten beei...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Nutzen von Arzneien könnte künftig EU-weit einheitlich geprüft werden

Nutzen von Arzneien könnte künftig EU-weit einheitlich geprüft werden


(dpa) - Neue Medikamente könnten künftig in einem europaweit einheitlichen Verfahren darauf geprüft werden, ob sie besser helfen als herkömmliche Präparate. Für das Vorhaben der EU-Kommission zeichne sich im Europaparlament vor der Abstimmung nächste Woche eine klare Mehrheit ab, sagte der CDU-Abgeo...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Vertrauen in Wissenschaft und Forschung bleibt stabil

Vertrauen in Wissenschaft und Forschung bleibt stabil


Trotz vielfach beklagter Elitenfeindlichkeit: Das Vertrauen der Menschen in Wissenschaft und Forschung bleibt laut Wissenschaftsbarometer 2018 im Vergleich zum Vorjahr stabil. Mit der repräsentativen Umfrage hat Wissenschaft im Dialog (WiD) zum fünften Mal die Einstellungen der Bürgerinnen und Bürge...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

UPDATE 3-Early approval of Alnylam's gene-silencing drug in question

UPDATE 3-Early approval of Alnylam's gene-silencing drug in question


Alnylam Pharmaceuticals Inc said on Thursday early data from its trial for gene-silencing drug givosiran showed it was effective, but added it might have to hold off on earlier plans to seek an accelerated approval from U.S. regulators. Shares in the Cambridge, Massachusetts-based developer fell nearly 4 percent to $87.72, after rising slightly in premarket trade.



from Biotech News
Share:

Hologic to Acquire Focal Therapeutics for $125 Million, Strengthening Breast Surgery Franchise

Hologic to Acquire Focal Therapeutics for $125 Million, Strengthening Breast Surgery Franchise


Sep 26, 2018--Hologic, Inc. , a global leader in women's health, announced today that it has signed a definitive agreement to acquire Focal Therapeutics, a privately-held company, for $125 million in cash. In conjunction with Hologic's recent acquisition of Faxitron Bioptics, Focal strengthens the Company's position in the rapidly growing market for breast conserving surgery.



from Biotech News
Share:

This Judge in Deadlocked Talc Trial Tried Everything to Get a Verdict, Transcripts Show

This Judge in Deadlocked Talc Trial Tried Everything to Get a Verdict, Transcripts Show


From the start of deliberations, the jury in a high-profile talcum powder trial against Johnson & Johnson last week was deadlocked. On the fourth day, Los Angeles Superior Court Judge Margaret Oldendorf brought each juror into the courtroom, one at a time.



from Biotech News
Share:

Plug and Play eröffnet das erste Health-Innovationsprogramm „Startup Creasphere“

Plug and Play eröffnet das erste Health-Innovationsprogramm „Startup Creasphere“


image description
Am 20 September eröffnete Plug and Play in Zusammenarbeit mit Roche, einem globalen Pionier in den Bereichen Pharma und Diagnostik, die größte Health-Innovation-Plattform in München. Plug and Play, der führende Technologieinvestor und Accelerator aus dem Silicon Valley, spezialisiert sich auf die En...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Über 600 Partnering-Gespräche beim ersten ECP Summer Summit

Über 600 Partnering-Gespräche beim ersten ECP Summer Summit


image description
Der erste ECP Summer Summit klang gestern mit einem internationalen Get Together in der Zentrale des Konsum- und Industriegüter-Unternehmens Henkel aus. 250 Teilnehmer kamen aus 16 Nationen, um sich disziplinenübergreifend über Innovationen auszutauschen: 606 Partnering-Gespräche fanden innerhalb vo...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Diarrhea-Causing Infection From Pet Store Puppies Linked To Outbreak In 18 States

Diarrhea-Causing Infection From Pet Store Puppies Linked To Outbreak In 18 States


Puppies are what the Centers for Disease Control and Prevention said has led to the illnesses in at least 18 states, as far west as Utah. The cause is campylobacter bacteria - which can trigger diarrhea, stomach pains and fever - and it's often resistant to antibiotics.



from Biotech News
Share:

Merck's Frazier to remain CEO of the US drugmaker beyond 2019

Merck's Frazier to remain CEO of the US drugmaker beyond 2019


Drugmaker Merck and Co Inc said on Wednesday that its board voted to rescind a policy requiring its head to retire at 65, a move that will permit current Chief Executive Officer Kenneth Frazier to remain in the role beyond next year. FILE PHOTO - Chairman and CEO of Merck & Co., Kenneth Frazier, takes part in a panel discussion during the Clinton Global Initiative's annual meeting in New York, September 27, 2015.



from Biotech News
Share:

How I Bought a Home in Philadelphia

How I Bought a Home in Philadelphia


In this series, NerdWallet interviews new homeowners across the country about their unique homebuying journeys and the financial decisions that helped them along the way. "I grew up in an Italian family who always said, 'You can never go wrong with buying property.'



from Biotech News
Share:

Renaissance Technologies LLC Decreases Holdings in Sinovac Biotech Ltd.

Renaissance Technologies LLC Decreases Holdings in Sinovac Biotech Ltd.


Renaissance Technologies LLC reduced its stake in Sinovac Biotech Ltd. by 4.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission . The fund owned 2,533,430 shares of the biopharmaceutical company's stock after selling 106,070 shares during the period.



from Biotech News
Share:

Syphilis cases in newborn babies reach 20-year high, CDC says

Syphilis cases in newborn babies reach 20-year high, CDC says


Congenital syphilis cases -- when a mother passes syphilis onto her baby during pregnancy or delivery -- have more than doubled in the United States since 2013, according to an report released Tuesday by the US Centers for Disease Control and Prevention. Congenital syphilis cases -- when a mother passes syphilis onto her baby during pregnancy or delivery -- have more than doubled in the United States since 2013, according to an report released Tuesday by the US Centers for Disease Control and Prevention.



from Biotech News
Share:

Pfizer, other drugmakers turn on each other in fight for new market

Pfizer, other drugmakers turn on each other in fight for new market


To continue reading this premium story, you need to become a member. Click below to take advantage of an exclusive offer for new members: A pharmacy counter in a Walgreens Boots Alliance store in Elmwood Park, Ill., on April 5, 2016.



from Biotech News
Share:

Jabil strikes deal with Johnson & Johnson that could grow revenue by more than $1 billion

Jabil strikes deal with Johnson & Johnson that could grow revenue by more than $1 billion


Jabil Inc. has struck a deal with Johnson & Johnson Medical Devices Cos. that CEO Mark Mondello says could be "transformational" for the St. Petersburg-based electronics manufacturer.



from Biotech News
Share:

La Jolla real estate agent faces child porn, molest charges

La Jolla real estate agent faces child porn, molest charges


A La Jolla real estate agent and guitarist for local tribute band Fooz Fighters had "thousands" of child pornography images on his phone and computer, a prosecutor said in court Tuesday. Donald Edward Hickey, 61, appeared in a San Diego Superior Court pre-trial arraignment and pleaded not guilty to 14 charges involving internet porn and sex acts on two girls.



from Biotech News
Share:

Finanzen: Kfz-Portaltest 2018 : Vergleichsportal Kfz-Versicherung

Wer die günstigste Kfz-Versicherung finden will, sollte auf einem Vergleichsportal und zusätzlich bei einem Direktversicherer Preise vergleichen.

from Finanztip Feed
Supported by Video Collection
Share:

GSK Vaccine Success a Milestone in TB, But Room for Improvement

GSK Vaccine Success a Milestone in TB, But Room for Improvement


An experimental GlaxoSmithKline vaccine could prevent tuberculosis developing in half of those who receive it, making it potentially the first new shot against the global killer in a century, researchers said on Tuesday. Given the failure of other candidates in recent years, it marks a milestone in the fight against TB, although the 54 percent efficacy rate achieved in adults in a mid-stage clinical trial is low compared to immunizations for other diseases.



from Biotech News
Share:

Newborn syphilis cases in US reach highest level in 20 years

Newborn syphilis cases in US reach highest level in 20 years


This 1972 microscope image provided by the Centers for Disease Control and Prevention shows a Treponema pallidum bacterium which causes the disease syphilis. A report released on Tuesday, Sept.



from Biotech News
Share:

Resistenz gegen das Krebsmedikament Cetuximab

Resistenz gegen das Krebsmedikament Cetuximab


image description
Forscher der Okayama University berichten, dass das Krebsmedikament Cetuximab mit Vesikeln aus Krebszellen freigesetzt wird, Erkenntnisse, die die Entwicklung von Strategien zur Verbesserung der Wirksamkeit von Cetuximab bei der Behandlung von Kopf- und Halskrebs ermöglichen können.Das Plattenepithe...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

It's rare that babies contract the Herpes simplex virus. If they do, it can be fatal.

It's rare that babies contract the Herpes simplex virus. If they do, it can be fatal.


Number of babies born with syphilis has more than doubled since 2013 The CDC reports a surge in cases of newborns with syphilis Check out this story on jacksonsun.com: https://usat.ly/2pBI8Po The number of babies born with syphilis surged from 362 in 2013 to 918 in 2017, the Centers for Disease Control and Prevention reported Tuesday. The number of babies born with syphilis has surged 154 percent since 2013, according to the Centers for Disease Control and Prevention, a trend that medical professionals said shows the need to be vigilant about testing and treating the potentially deadly disease.



from Biotech News
Share:

Number of babies born with syphilis has more than doubled since 2013...

Number of babies born with syphilis has more than doubled since 2013...


Number of babies born with syphilis has more than doubled since 2013 The CDC reports a surge in cases of newborns with syphilis Check out this story on ydr.com: https://usat.ly/2pBI8Po The number of babies born with syphilis surged from 362 in 2013 to 918 in 2017, the Centers for Disease Control and Prevention reported Tuesday. The number of babies born with syphilis has surged 154 percent since 2013, according to the Centers for Disease Control and Prevention, a trend that medical professionals said shows the need to be vigilant about testing and treating the potentially deadly disease.



from Biotech News
Share:

Dance Biopharm Holdings announces the appointment of Anne Whitaker as Chief Executive Officer

Dance Biopharm Holdings announces the appointment of Anne Whitaker as Chief Executive Officer


Dance Biopharm Holdings Inc. , a private biotechnology company focused on developing transformational healthcare solutions to treat diabetes and other serious chronic diseases, is pleased to announce that Anne Whitaker has been appointed as a Director and Chief Executive Officer. Ms. Whitaker will take up her new position on October 1st, 2018.



from Biotech News
Share:

Glenmede Trust Co. NA Has $5.56 Million Stake in GlaxoSmithKline plc

Glenmede Trust Co. NA Has $5.56 Million Stake in GlaxoSmithKline plc


Glenmede Trust Co. NA decreased its holdings in shares of GlaxoSmithKline plc by 2.5% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission.



from Biotech News
Share:

Why Puerto Rico plays a vital role in agriculture

Why Puerto Rico plays a vital role in agriculture


For a region the size of Connecticut, Puerto Rico packs a big punch when it comes to its contribution to world agriculture. Many people are unaware, that the 5,335-square-mile commonwealth is the research and development headquarters for up to 85 percent of the commercial corn, soybean and other hybrid seeds grown in the U.S. It is part of a biotech industry that has been thriving for 35 years.



from Biotech News
Share:

The Daily Biotech Pulse: Syndax Lung Cancer Trial Disappoints,...

The Daily Biotech Pulse: Syndax Lung Cancer Trial Disappoints,...


Syndax Pharmaceuticals Inc released updated results from its Phase 2 study dubbed ENCORE 601 that evaluated its Entinostat in combination with Merck's Keytruda for treating non-small cell lung cancer, or NSCLC, previously treated with both chemotherapy and PD- 1 therapy. At the time of data cut-off, there were seven confirmed partial responses among the overall population of 72 efficacy-evaluable patients, for a 10 percent objective response rate, a median duration of response of 5.3 months, and a median progression free survival of 2.8 months, the company said.



from Biotech News
Share:

Finanzen: Kfz-Versicherung : Kfz-Versicherungsvergleich

Wenn Sie bei der Kfz-Versicherung sparen möchten, kommen Sie um einen Onlinevergleich nicht herum. Wir zeigen Ihnen, wie Sie verschiedene Vergleichsportale clever kombinieren, um den günstigsten und besten Tarif zu bekommen.

from Finanztip Feed
Supported by Video Collection
Share:

Biotechnology Industry Data Survey Shows Competition for Investment and Talent Remain Real

Biotechnology Industry Data Survey Shows Competition for Investment and Talent Remain Real


Sep 24, 2018--Poised as a vital component of Canada's push to develop more knowledge-intensive industries, Canada's biotechnology sector is composed of many early-stage companies that are expecting significant growth in the future. The survey results underscore the reality that the search for talent and investment will continue as an important industry priority for the immediate period ahead.



from Biotech News
Share:

Gilead to launch generic versions of its hepatitis drugs

Gilead to launch generic versions of its hepatitis drugs


Gilead Sciences Inc said on Monday it plans to launch generic versions of its hepatitis C drugs in the United States, at a time when regulators are looking to lower healthcare costs. FILE PHOTO: A Gilead Sciences, Inc. logo is seen outside the company headquarters in Foster City, California, U.S. May 1, 2018.



from Biotech News
Share:

Aurelia Evacuation: The Impact of Anhydrous Ammonia

Aurelia Evacuation: The Impact of Anhydrous Ammonia


Anhydrous ammonia is a colorless gas with pungent, suffocating fumes - and is not something to take lightly if exposure takes place. According to the Centers for Disease Control and Prevention, as liquid anhydrous ammonia is released into the air, it expands rapidly, forming a large cloud that acts as a heavier-than-air gas for a period of time.



from Biotech News
Share:

LI biotech and life science companies seek private funding to reach full potential

LI biotech and life science companies seek private funding to reach full potential


Rep. Tom Suozzi discusses the 495 Research Corridor on Hi Tech Island during a Biotechnology & Life Sciences Conference at LIU on Monday in Greenvale. Photo Credit: Howard Schnapp Long Island's cluster of biotechnology and life science companies, already heavily supported by federal grants, needs an infusion of private sector dollars to meet their full potential, Rep. Thomas Suozzi and industry leaders said Monday at a conference in Greenvale.



from Biotech News
Share:

Finanzen: Wertpapierdepot : Depot-Vergleich

Wer in Wertpapiere investieren will, braucht ein Depot. Wir haben untersucht, wo Sie besonders preiswert online Aktien handeln können und welche Depotbanken am benutzerfreundlichsten sind.

from Finanztip Feed
Supported by Video Collection
Share:

Novartis streicht in der Schweiz über 2000 Stellen

Novartis streicht in der Schweiz über 2000 Stellen


(dpa-AFX) - Novartis will in der Schweiz rund 2 150 Stellen innerhalb von vier Jahren abbauen. Rund 1450 Arbeitsplätze gehen in der Produktion in Basel, Schweizerhalle, Stein und Locarno verloren. Weitere 700 Stellen im Dienstleistungsbereich werden ins Ausland verlagert. Im Gegenzug werden man durc...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Centrexion Therapeutics Appoints Andrew Partridge as Executive Vice President, Chief Commercial Officer

Centrexion Therapeutics Appoints Andrew Partridge as Executive Vice President, Chief Commercial Officer


Sep 24, 2018--Centrexion Therapeutics Corporation, a company focused on developing novel, non-opioid and non-addictive therapies for the treatment of chronic pain, today announced that Andrew Partridge has been appointed Executive Vice President, Chief Commercial Officer of the company. "We are very pleased to have Andrew join the Centrexion leadership team," said Jeffrey B. Kindler, chief executive officer of Centrexion Therapeutics.



from Biotech News
Share:

Mit Viren gegen resistente Bakterien

Mit Viren gegen resistente Bakterien


image description
Die Ausbreitung von Antibiotikaresistenzen gilt als große Bedrohung für die globale Gesundheit. Weltweit starben bislang rund 700.000 Menschen durch das Nicht-Wirken von antibakteriellen Medikamenten. Schätzungen zufolge wird diese Anzahl bis zum Jahr 2050 auf jährlich rund zehn Millionen Todesfälle...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Northern Trust Corp Increases Holdings in Regeneron Pharmaceuticals Inc

Northern Trust Corp Increases Holdings in Regeneron Pharmaceuticals Inc


Northern Trust Corp boosted its stake in Regeneron Pharmaceuticals Inc by 2.0% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 934,245 shares of the biopharmaceutical company's stock after acquiring an additional 17,931 shares during the period.



from Biotech News
Share:

Andra AP fonden Sells 4,700 Shares of Vertex Pharmaceuticals Incorporated

Andra AP fonden Sells 4,700 Shares of Vertex Pharmaceuticals Incorporated


Andra AP fonden lessened its stake in Vertex Pharmaceuticals Incorporated by 12.1% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,300 shares of the pharmaceutical company's stock after selling 4,700 shares during the period.



from Biotech News
Share:

AngioSoma Announces New Ecommerce Platform Featuring Innovative Products

AngioSoma Announces New Ecommerce Platform Featuring Innovative Products


Sep 24, 2018--AngioSoma announced today the launch of their new ecommerce site for its retail brand, SomaCeuticals. The site, YouthfulBrilliance.com , features products within the Nutraceutical and Cosmeceutical industries currently with a future roadmap to expand product offerings with key partnerships and their growing Amazon storefront.



from Biotech News
Share:

Finanzen: Trennungsunterhalt : Trennungsunterhalt

Trotz einer Trennung sind Eheleute weiter füreinander verantwortlich – auch in finanzieller Hinsicht. Wer mehr verdient, muss meist Trennungsunterhalt zahlen.

from Finanztip Feed
Supported by Video Collection
Share:

Flu shots a pinch in the arm, but not always in the wallet

Flu shots a pinch in the arm, but not always in the wallet


A nurse prepares a flu shot on Feb. 7 at the Salvation Army in Atlanta. According to the CDC, flu costs the nation about $7 billion a year in sick days and lost productivity among working-age adults.



from Biotech News
Share:

FOCUS-As China builds biotech sector, cash floods U.S. startups

FOCUS-As China builds biotech sector, cash floods U.S. startups


For three whirlwind days in June, U.S. scientist Zhi Hong went shopping at the Boston Bio Conference to find drugs to fill the pipeline of his two-week-old drug company. FILE PHOTO: A scientist works at Zai Labo's drug development facility in Shanghai, China October 18, 2017.



from Biotech News
Share:

As China builds biotech sector, cash floods US startups

As China builds biotech sector, cash floods US startups


For three whirlwind days in June, U.S. scientist Zhi Hong went shopping at the Boston Bio Conference to find drugs to fill the pipeline of his two-week-old drug company. FILE PHOTO: A scientist works at Zai Labo's drug development facility in Shanghai, China October 18, 2017.



from Biotech News
Share:

Energy sector unable to lift ASX as CSL weighs

Energy sector unable to lift ASX as CSL weighs


Australian shares have closed lower on a mixed day of trading as positive gains from the energy sector were wiped by CSL and materials sector losses. The S&P/ASX 200 index closed 7.7 points, or 0.1 per cent, lower at 6186.9, rallying from a 25 point loss at the open.



from Biotech News
Share:

Drugmakers Face U.S. Investigation

Drugmakers Face U.S. Investigation


Drug companies say the services, such as nurses and reimbursement assistance, help doctors and patients. But the practices, which have become more prevalent as drugmakers have introduced more complex and expensive drugs, are drawing scrutiny over whether they serve an illegal commercial purpose: inducing sales.



from Biotech News
Share:

Zika und Gelbfieber: Impfstoffe ohne Ei

Zika und Gelbfieber: Impfstoffe ohne Ei


image description
Die Versorgung mit einigen lebenswichtigen Impfstoffen könnte in Zukunft sicherer werden. Ein Team um Forscher des Max-Planck-Instituts für Dynamik komplexer technischer Systeme in Magdeburg entwickelt Methoden, mit denen sich Viren für Impfstoffe in deutlich höherer Konzentration vermehren lassen a...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Royal London Asset Management Ltd. Takes Position in McKesson Co.

Royal London Asset Management Ltd. Takes Position in McKesson Co.


Royal London Asset Management Ltd. bought a new position in shares of McKesson Co. during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.



from Biotech News
Share:

Johnson & Johnson (JNJ) Shares Bought by Handelsbanken Fonder AB

Johnson & Johnson (JNJ) Shares Bought by Handelsbanken Fonder AB


Handelsbanken Fonder AB raised its stake in Johnson & Johnson by 1.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission . The institutional investor owned 643,084 shares of the company's stock after acquiring an additional 10,638 shares during the period.



from Biotech News
Share:

Douglass Winthrop Advisors LLC Has $2.03 Million Holdings in Pfizer Inc.

Douglass Winthrop Advisors LLC Has $2.03 Million Holdings in Pfizer Inc.


Douglass Winthrop Advisors LLC grew its stake in Pfizer Inc. by 8.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 55,949 shares of the biopharmaceutical company's stock after acquiring an additional 4,536 shares during the quarter.



from Biotech News
Share:

Brokerages Expect Progenics Pharmaceuticals, Inc. (PGNX) Will Announce Earnings of -$0.18 Per Share

Brokerages Expect Progenics Pharmaceuticals, Inc. (PGNX) Will Announce Earnings of -$0.18 Per Share


Equities research analysts expect Progenics Pharmaceuticals, Inc. to report earnings per share of for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Progenics Pharmaceuticals' earnings.



from Biotech News
Share:

Critical Analysis: Halozyme Therapeutics

Critical Analysis: Halozyme Therapeutics


Halozyme Therapeutics and Proteon Therapeutics are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability and analyst recommendations. This is a summary of recent ratings and target prices for Halozyme Therapeutics and Proteon Therapeutics, as reported by MarketBeat.



from Biotech News
Share:

SRS Capital Advisors Inc. Raises Holdings in Amgen, Inc.

SRS Capital Advisors Inc. Raises Holdings in Amgen, Inc.


SRS Capital Advisors Inc. raised its stake in Amgen, Inc. by 21.3% in the second quarter, HoldingsChannel.com reports. The fund owned 2,391 shares of the medical research company's stock after buying an additional 420 shares during the quarter.



from Biotech News
Share:

Fondren Management LP Grows Holdings in Trinity Biotech plc

Fondren Management LP Grows Holdings in Trinity Biotech plc


Fondren Management LP raised its holdings in shares of Trinity Biotech plc by 35.0% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 135,000 shares of the company's stock after purchasing an additional 35,000 shares during the period.



from Biotech News
Share:

Jane Street Group LLC Acquires New Stake in Dr.Reddy's Laboratories Ltd

Jane Street Group LLC Acquires New Stake in Dr.Reddy's Laboratories Ltd


Jane Street Group LLC acquired a new position in shares of Dr.Reddy's Laboratories Ltd in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission . The institutional investor acquired 134,528 shares of the company's stock, valued at approximately $4,332,000.



from Biotech News
Share:

Why Puerto Rico plays a vital role in agriculture

Why Puerto Rico plays a vital role in agriculture


For a region the size of Connecticut, Puerto Rico packs a big punch when it comes to its contribution to world agriculture.



from Biotech News
Share:

SPDR S&P Biotech Etf (Xbi) Announces Quarterly Dividend of $0.07

SPDR S&P Biotech Etf (Xbi) Announces Quarterly Dividend of $0.07


SPDR S&P Biotech ETF announced a quarterly dividend on Friday, September 21st, Wall Street Journal reports. Shareholders of record on Monday, September 24th will be paid a dividend of 0.0726 per share by the exchange traded fund on Wednesday, September 26th.



from Biotech News
Share:

Widow of BigLaw partner loses en banc petition in wrongful-death lawsuit

Widow of BigLaw partner loses en banc petition in wrongful-death lawsuit


The Chicago-based 7th U.S. Circuit Court of Appeals on Thursday denied a petition to rehear a wrongful-death finding involving GlaxoSmithKline and a former Reed Smith partner who died by suicide while taking a generic version of the prescribed antidepressant Paxil. Wendy Dolin, who was Stewart Dolin's wife, alleged that GSK failed to warn people that the drug could cause suicide deaths in older users, Bloomberg Big Law Business reports.



from Biotech News
Share:

US Alzheimer's, dementia burden to double by 2060, CDC warns Source: Cox Media Group

US Alzheimer's, dementia burden to double by 2060, CDC warns Source: Cox Media Group


The Atlanta-based Centers for Disease Control and Prevention on Thursday revealed that the country's burden of Alzheimer's disease and related dementias will double by the year 2060. In 2014, 5 million Americans - or 1.6 percent of the population - felt the burden of the diseases.



from Biotech News
Share:

Most actively traded companies on the TSX

Most actively traded companies on the TSX


Aurora Cannabis Inc. . Health care. Down 41 cents, or 3.35 per cent, to $11.84 on 43.4 million shares.



from Biotech News
Share:

Biotech developing cancer drugs kicks off $13M round with pitch contest win

Biotech developing cancer drugs kicks off $13M round with pitch contest win


Rockville-based biotechnology company Remedy Plan Therapeutics took home $5,000 Thursday as the winner of the Maryland Tech Council's inaugural Bio+Tech18 pitch competition. That money will go toward a larger, $13 million round the company is looking to raise to fuel development of its first drug product.



from Biotech News
Share:

Nestl , Unilever and Coca-Cola fight it out over GSK's 3.4bn Horlicks unit

Nestl , Unilever and Coca-Cola fight it out over GSK's 3.4bn Horlicks unit


FMCG giants Unilever, Coca-Cola and NestlA© are set to compete for GlaxoSmithKline's nutrition business unit ahead of an auction later this year, reports say. Reports from the Financial Times and Reuters suggest that four bids have already been made, with a $4bn USD deal expected to be wrapped up before the end of the year.



from Biotech News
Share:

Q3 2019 Earnings Estimate for AmerisourceBergen Corp. (ABC) Issued By Leerink Swann

Q3 2019 Earnings Estimate for AmerisourceBergen Corp. (ABC) Issued By Leerink Swann


AmerisourceBergen Corp. - Investment analysts at Leerink Swann lowered their Q3 2019 EPS estimates for AmerisourceBergen in a note issued to investors on Thursday, September 20th. Leerink Swann analyst D. Larsen now expects that the company will earn $1.58 per share for the quarter, down from their prior forecast of $1.61.



from Biotech News
Share:

What is a blue-chip stock, and why are they favored? Ask A Fool

What is a blue-chip stock, and why are they favored? Ask A Fool


Question: I'm new to investing and have heard the term "blue chip" used in reference to certain stocks. What exactly is a blue-chip stock? Answer: Blue-chip stocks are the best of the best in the stock market.



from Biotech News
Share:

Capital Fund Management S.A. Reduces Position in Inogen Inc

Capital Fund Management S.A. Reduces Position in Inogen Inc


Capital Fund Management S.A. reduced its position in shares of Inogen Inc by 84.7% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 1,100 shares of the medical technology company's stock after selling 6,100 shares during the period.



from Biotech News
Share:

Animal health firm Elanco surges 41 percent on debut

Animal health firm Elanco surges 41 percent on debut


Elanco Animal Health's shares climbed 36 percent in their stock market debut on Thursday, in a sign of investor enthusiasm for the fast-growing pet healthcare market. Elanco Animal Health Inc. President and CEO Jeff Simmons, speaks at the company's IPO at the New York Stock Exchange in New York, U.S., September 20, 2018.



from Biotech News
Share:

Finanzen: Telematik : Telematik im Auto

Mit Telematik können gerade junge Autofahrer die teuren Prämien der Kfz-Versicherung drücken. Doch nur, wenn sie ein umsichtiges Fahrverhalten an den Tag legen und einige Daten von sich preisgeben.

from Finanztip Feed
Supported by Video Collection
Share:

-$0.14 EPS Expected for Moleculin Biotech Inc (MBRX) This Quarter

-$0.14 EPS Expected for Moleculin Biotech Inc (MBRX) This Quarter


Equities research analysts expect Moleculin Biotech Inc to post earnings per share for the current quarter, according to Zacks Investment Research . Zero analysts have made estimates for Moleculin Biotech's earnings.



from Biotech News
Share:

Study reveals new way to target HER2-negative metastatic breast cancer

Study reveals new way to target HER2-negative metastatic breast cancer


A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target. A research team led by Karolina Palucka, M.D., Ph.D., a professor at The Jackson Laboratory , has collaborated with researchers at The Baylor Institute for Immunology Research to show that IL1b, a member of the interleukin 1 family of cytokines drives the inflammation often found in cancer, and appears as an "IL1 signature" in women with HER2-negative metastatic breast cancer .



from Biotech News
Share:

Finanzen: Ehegattensplitting : Ehegattensplitting

Ehepaare sparen bei einer Zusammenveranlagung Steuern - insbesondere bei einem hohen Einkommensunterschied. Sie profitieren vom Splittingtarif.

from Finanztip Feed
Supported by Video Collection
Share:

The 7 Best Biotech Stocks for Investors Who Hate Risk

The 7 Best Biotech Stocks for Investors Who Hate Risk


Most of the buy-and-hold crowd tends to steer clear of biotech stocks, and for good reason. Biotechnology companies can be uncomfortably risky.



from Biotech News
Share:

Arena Pharmaceuticals to Present at Upcoming Investor Conferences

Arena Pharmaceuticals to Present at Upcoming Investor Conferences


SAN DIEGO, Sept. 20, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. today announced that members of its senior management team will participate in the upcoming investor conferences: Cantor Global Healthcare Conference - Presenting on Tuesday, October 2, at 1:40 p.m. EDT in New York CityLeerink Partners Roundtable Series - Rare Disease & Oncology - Presenting on Tuesday, October 2, at 2:00 p.m. EDT in New York City A live audio webcast of the presentations will be available under the investor relations section of Arena's website at www.arenapharm.com .



from Biotech News
Share:

Castleark Management LLC Has $5.56 Million Stake in Array Biopharma Inc

Castleark Management LLC Has $5.56 Million Stake in Array Biopharma Inc


Castleark Management LLC lifted its stake in shares of Array Biopharma Inc by 42.9% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 331,435 shares of the biopharmaceutical company's stock after buying an additional 99,430 shares during the quarter.



from Biotech News
Share:

Immuno-Oncology Players Gritstone And Sutro Join The Biotech IPO Frenzy

Immuno-Oncology Players Gritstone And Sutro Join The Biotech IPO Frenzy


Investors are bullish on biotech research focused on cancer, despite the uncertainty that the science will translate to marketable products. So far, 38 biotechnology companies have gone public in 2018, raising nearly $4 billion, according to figures released by Bloomberg last week.



from Biotech News
Share:

S.Korean stocks climb on electronics, biotech boost; won gains

S.Korean stocks climb on electronics, biotech boost; won gains


The Korean won and bond yields also edged higher. ** At 02:37 GMT, the KOSPI was up 16.96 points or 0.73 percent at 2,325.42.



from Biotech News
Share:

Finanzen: Ratgeber Ratenkredit : Kredit und Darlehen

Wer einen Kredit aufnehmen will, erhält über Vergleichsportale Angebote unterschiedlicher Banken. Auf dem Weg zum Kredit sollten Verbraucher mehr als ein Portal nutzen.

from Finanztip Feed
Supported by Video Collection
Share:

What to know about the deadly Eastern equine encephalitis virus found ...

What to know about the deadly Eastern equine encephalitis virus found ...


The DeKalb County health department in metro Atlanta recently announced that a mosquito in the area tested positive for the deadly Eastern equine encephalitis virus. "It's a very serious illness if it is to infect a person," Ryan Cira, the environmental health director for the DeKalb Board of Health, told the Atlanta Journal-Constitution , though humans are rarely infected by the virus.



from Biotech News
Share:

Oncolytics Biotech Provides Corporate and Clinical Update

Oncolytics Biotech Provides Corporate and Clinical Update


Oncolytics BiotechA Inc. , currently developing pelareorep, an intravenously delivered immuno-oncolytic virus turning cold tumors hot, today announced a corporate update would be provided in a conference call and webcast covering both business and clinical development activities. Management will host a webcast and conference call on Thursday, September 20 at 8:30 a.m. EDT to discuss the update in detail with investors and analysts.



from Biotech News
Share:

Cellect Biotech/S (Apop) Given $14.00 Consensus Target Price by Analysts

Cellect Biotech/S (Apop) Given $14.00 Consensus Target Price by Analysts


CELLECT BIOTECH/S has received a consensus broker rating score of 1.00 from the one brokers that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy rating.



from Biotech News
Share:

Virotherapie bei Bauchfellkrebs erfolgreich getestet

Virotherapie bei Bauchfellkrebs erfolgreich getestet


Krebserkrankungen, die das Bauchfell betreffen, gehören zu den am schwersten zu behandelnden Tumorerkrankungen. Trotz enormer Anstrengungen haben klassische Therapieverfahren wie Chemotherapie oft keinen Erfolg. Die Virotherapie stellt eine vollkommen neue, biologische Krebstherapie dar. Dabei werde...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

UPDATE 1-UK rejects adult Novartis CAR-T therapy, after 'yes' in kids

UPDATE 1-UK rejects adult Novartis CAR-T therapy, after 'yes' in kids


Health authorities in England have rejected a pricey CAR-T cell therapy from Novartis for adults with blood cancer, two weeks after endorsing its use in children and young people. The National Institute for Health and Care Excellence said Kymriah was not cost-effective for adult lymphoma.



from Biotech News
Share:

Bayer Steps Up Fight Over Weed Killer Blamed for Cancer

Bayer Steps Up Fight Over Weed Killer Blamed for Cancer


Bayer AG is stepping up the legal defense of its flagship weed killer, after a verdict in a recent case alleging the chemical causes cancer sent shares down sharply and raised the prospect of costly plaintiff payouts. Bayer on Tuesday said it wants a California state court judge to overturn the jury's verdict, order a new trial or reduce damages, according to a court filing.



from Biotech News
Share:

Diversity, science leadership grants awarded to student-faculty pairs

Diversity, science leadership grants awarded to student-faculty pairs


Two graduate students and their respective faculty advisers were awarded grants for scientific leadership and dedication to diversity and inclusion in the sciences. Two graduate students at the School of Medicine and their faculty advisers have been awarded fellowship grants by the Howard Hughes Medical Institute .



from Biotech News
Share:

Maryland Tech Council taps biotech industry veteran as new CEO

Maryland Tech Council taps biotech industry veteran as new CEO


The Maryland Tech Council has appointed 35-year biotech industry veteran Martin "Marty" Rosendale as its new CEO, effective immediately.



from Biotech News
Share:

Bayer's Monsanto asks U.S. court to toss $289 million glyphosate verdict

Bayer's Monsanto asks U.S. court to toss $289 million glyphosate verdict


Bayer AG unit Monsanto on Tuesday asked a California judge to throw out a $289 million jury verdict awarded to a man who alleged the company's glyphosate-based weed-killers, including Roundup, gave him cancer. FILE PHOTO: Monsanto's Roundup weedkiller atomizers are displayed for sale at a garden shop near Brussels, Belgium, November 27, 2017.



from Biotech News
Share:

McHenry County Department of Health encourages flu shots

McHenry County Department of Health encourages flu shots


Influenza season runs from October to May in Illinois. Usually between 10 percent and 20 percent of the population is affected, according to the Illinois Department of Public Health.



from Biotech News
Share:

McKesson Co. (MCK) Holdings Increased by Verition Fund Management LLC

McKesson Co. (MCK) Holdings Increased by Verition Fund Management LLC


Verition Fund Management LLC grew its holdings in McKesson Co. by 731.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission.



from Biotech News
Share:

Finanzen: Alternativen zum ADAC : ADAC-Alternative

Viele Autofahrer glauben, im Fall einer Panne auf den ADAC angewiesen zu sein. Doch es gibt gute Alternativen. Manche sind deutlich billiger.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Trennung : Trennung vom Ehepartner

Wenn es in der Ehe heftig kriselt und eine Trennung im Raum steht, gibt es viele Dinge, die Sie regeln müssen. Unsere Checkliste hilft Ihnen, nichts Wichtiges zu vergessen.

from Finanztip Feed
Supported by Video Collection
Share:

Exclusive: Nestle, Unilever, Coke make bids in $4 billion-plus GSK India sale - sources

Exclusive: Nestle, Unilever, Coke make bids in $4 billion-plus GSK India sale - sources


FILE PHOTO: A GlaxoSmithKline logo is seen outside one of its buildings in west London, February 6, 2008. REUTERS/Toby Melville/File Photo Initial bids were due on Monday and the three consumer goods giants are seen as frontrunners for a business that offers a significant footprint in a fast-growing emerging market.



from Biotech News
Share:

400 Millionen Euro: Roche baut Mannheimer Standort aus

400 Millionen Euro: Roche baut Mannheimer Standort aus


image description
Roche baut mit Investitionen von über 400 Millionen Euro in fünf große Bauprojekte seinen Hightech-Standort in Mannheim aus. Heute weiht das Gesundheitsunternehmen die neuen Gebäude ein. Mit dabei: Prominenz aus Politik und Wirtschaft. „Es ist die größte Einzelinvestition in der Geschichte des Mannh...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

3 High-Quality Biotech Companies for 4th Quarter

3 High-Quality Biotech Companies for 4th Quarter


On Monday, GuruFocus' High Quality Screener listed three biotechnology companies that offer good potential ahead of the fourth quarter: Biogen Inc. , Gilead Sciences Inc. and Novo Nordisk A/S . Berkshire Hathaway Inc. CEO Warren Buffett has stressed several times that key investing criteria include predictable earnings and strong economic moat.



from Biotech News
Share:

Precision Medicine in Cancers and Non-Communicable Diseases

Precision Medicine in Cancers and Non-Communicable Diseases


Welcome to CRCPress.com! We have customized the Taylor & Francis India website to host CRC Press titles. Please choose www.TandFIndia.com to get the following benefits: All instructor resources are now available on our Instructor Hub .



from Biotech News
Share:

Silicon Valley's top biotech VCs share the biggest mistakes startups make when they pitch

Silicon Valley's top biotech VCs share the biggest mistakes startups make when they pitch


Biotech is one of the hottest sectors for venture-capital funds right now, but pitching a science-heavy startup to investors isn't always easy. We asked the top investors in the space to tell us what startup leaders do wrong when they try to attract venture funding - and what they can do to avoid these pitfalls.



from Biotech News
Share:

Finanzen: Handy-Partnervertrag : Handy-Partnervertrag

Mit einem Handy-Partnervertrag sollen Familien und (Ehe-)Paare sparen können. Doch lohnen sich Partnertarife von Telekom, Vodafone und O2 wirklich?

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Dienstfahrrad : Dienstfahrrad versteuern

Ein Dienstfahrrad, das auch privat genutzt wird, ist vom Arbeitnehmer ähnlich zu versteuern wie ein Dienstauto. Ein Rad über den Arbeitgeber zu leasen lohnt sich in vielen Fällen.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Günstige Bahn-Tickets : Deutsche Bahn

Bahn fahren ist komfortabel, manchen aber zu teuer. So kommen Sie an günstigere Fahrkarten.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Wechsel Messstellenbetreiber : Messstellenbetreiber wechseln

Digitale Stromzähler ziehen in alle Haushalte ein. Sie können 100 Euro pro Jahr kosten. Doch es geht auch anders: Wechseln Sie zu einem günstigeren Anbieter.

from Finanztip Feed
Supported by Video Collection
Share:

Regeneron bursting at the seams in East Greenbush

Regeneron bursting at the seams in East Greenbush


Land is cleared on Temple Lane where Regeneron plans to add several new structures to its growing campus on Tuesday, Sept. 11 2018, in East Greenbush, N.Y. Land is cleared on Temple Lane where Regeneron plans to add several new structures to its growing campus on Tuesday, Sept.



from Biotech News
Share:

Almost one in 11 U.S. tweens and teens vape cannabis

Almost one in 11 U.S. tweens and teens vape cannabis


Nearly one in three young e-cigarette users said they had tried cannabis with e-cigarettes at least once, survey results showed. Overall, almost 9 percent of students had vaped marijuana, including 4.5 percent of students in middle school and 12.4 percent of students in high school.



from Biotech News
Share:

Mit Nano-Lenkraketen Keime töten

Mit Nano-Lenkraketen Keime töten


image description
Wo Antibiotika versagen, könnten künftig Nano-Lenkraketen helfen, multiresistente Erreger (MRE) zu bekämpfen: Dieser Idee gehen derzeit Wissenschaftler der Universität Duisburg-Essen (UDE) und der Medizinischen Hochschule Hannover nach. Zusammen mit einem führenden US-Experten tüfteln sie an million...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

This cancer-fighting biotech sped from startup to IPO filing in 10 months

This cancer-fighting biotech sped from startup to IPO filing in 10 months


The team that took Kite Pharma from a startup re-engineering a patient's own cells to fight cancer to a $12 billion buyout now is seeking a $100 million initial public offering for the South San Francisco company it launched only 10 months ago. Arie Belldegrun and David Chang co-founded Allogene Therapeutics Inc. to develop off-the-shelf cells derived from healthy donors that could be used in a variety of cancer patients.



from Biotech News
Share:

Hengehold Capital Management LLC Has $3.05 Million Stake in Pfizer Inc.

Hengehold Capital Management LLC Has $3.05 Million Stake in Pfizer Inc.


Hengehold Capital Management LLC raised its stake in shares of Pfizer Inc. by 15.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 84,124 shares of the biopharmaceutical company's stock after buying an additional 11,085 shares during the quarter.



from Biotech News
Share:

Survey finds 2 million US teens are vaping marijuana

Survey finds 2 million US teens are vaping marijuana


The number is worrying "because cannabis use among youth can adversely affect learning and memory and may impair later academic achievement and education," said lead researcher Katrina Trivers of the Centers for Disease Control and Prevention. A school-based survey shows nearly 1 in 11 U.S. students have used marijuana in electronic cigarettes, heightening concern about the new popularity of vaping among teens.



from Biotech News
Share:

FY2021 EPS Estimates for Gilead Sciences, Inc. (GILD) Raised by Analyst

FY2021 EPS Estimates for Gilead Sciences, Inc. (GILD) Raised by Analyst


Gilead Sciences, Inc. - Leerink Swann raised their FY2021 earnings per share estimates for shares of Gilead Sciences in a note issued to investors on Wednesday, September 12th. Leerink Swann analyst G. Porges now forecasts that the biopharmaceutical company will earn $6.80 per share for the year, up from their previous estimate of $6.79.



from Biotech News
Share:

Eli Lilly And Co (LLY) Expected to Announce Earnings of $1.35 Per Share

Eli Lilly And Co (LLY) Expected to Announce Earnings of $1.35 Per Share


Brokerages expect Eli Lilly And Co to post earnings per share of $1.35 for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Eli Lilly And Co's earnings.



from Biotech News
Share:

HRT Financial LLC Acquires New Position in SPDR S&P Biotech Etf

HRT Financial LLC Acquires New Position in SPDR S&P Biotech Etf


HRT Financial LLC acquired a new position in SPDR S&P Biotech ETF during the 2nd quarter, HoldingsChannel reports. The fund acquired 2,842 shares of the exchange traded fund's stock, valued at approximately $270,000.



from Biotech News
Share:

Weltweite Zahl der Krebsdiagnosen steigt

Weltweite Zahl der Krebsdiagnosen steigt


(dpa) Die Zahl neuer Krebsdiagnosen steigt einem Bericht zufolge weltweit. Im Jahr 2018 werden es demnach schätzungsweise 18,1 Millionen entdeckte Fälle sein. Ursachen seien unter anderem die verbesserten Diagnosemöglichkeiten, das Bevölkerungswachstum und die längere Lebenserwartung der Menschen, t...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Neue Verunreinigung in Valsartan gefunden

Neue Verunreinigung in Valsartan gefunden


(dpa) Im Skandal um verunreinigte Blutdrucksenker mit dem Wirkstoff Valsartan geht die Europäische Arzneimittel-Agentur (EMA) von einem geringen Krebsrisiko für Patienten aus. Wer ein betroffenes Präparat in der höchsten Dosierung von 320 Milligramm täglich von Juli 2012 bis Juli 2018 genommen habe,...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Finanzen: Unterhaltspflicht von Kindern für Eltern : Unterhaltspflicht gegenüber Eltern

Kinder müssen die Kosten für die Pflege ihrer Eltern im Heim zum Teil mittragen. Wir haben für Sie zusammengestellt, was finanziell auf Sie zukommen könnte.

from Finanztip Feed
Supported by Video Collection
Share:

Bruderman Asset Management LLC Decreases Holdings in GlaxoSmithKline plc

Bruderman Asset Management LLC Decreases Holdings in GlaxoSmithKline plc


Bruderman Asset Management LLC trimmed its position in shares of GlaxoSmithKline plc by 34.6% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 170,097 shares of the pharmaceutical company's stock after selling 89,896 shares during the period.



from Biotech News
Share:

Zacks: Brokerages Anticipate La Jolla Pharmaceutical (LJPC) Will Post ...

Zacks: Brokerages Anticipate La Jolla Pharmaceutical (LJPC) Will Post ...


Wall Street analysts expect La Jolla Pharmaceutical to report sales of $3.38 million for the current quarter, according to Zacks Investment Research . Four analysts have provided estimates for La Jolla Pharmaceutical's earnings.



from Biotech News
Share:

Sanofi richtet zwei globale Geschäftseinheiten neu aus

Sanofi richtet zwei globale Geschäftseinheiten neu aus


Sanofi wird die Organisationstruktur von zwei globalen Business Units (GBUs) ändern, um das Geschäft in den etablierten Märkten und in den Schwellenländer noch gezielter auszurichten. Das Unternehmen wird eine neue GBU Primary Care implementieren, in der die Produktportfolios der bestehenden GBU Dia...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

MorphoSys und Galapagos informieren über Beginn von Phase 1-Vergleichstudie mit subkutaner Verabreichung von MOR106

MorphoSys und Galapagos informieren über Beginn von Phase 1-Vergleichstudie mit subkutaner Verabreichung von MOR106


Die MorphoSys AG und Galapagos NV gaben den Beginn einer Phase 1-Vergleichsstudie ("bridging study") bekannt, um eine subkutane Verabreichung von MOR106 zu erproben. MOR106 ist ein gegen das Zielmolekül IL-17C gerichteter Antikörper in klinischer Entwicklung. Bei dieser Vergleichsstudie handelt es s...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Urteil: Patent auf Hepatitis-Medikament bleibt mit Änderungen

Urteil: Patent auf Hepatitis-Medikament bleibt mit Änderungen


(dpa) Das US-Pharma-Unternehmen Gilead darf sein umstrittenes Patent auf ein Hepatitis-C-Medikament behalten - allerdings mit Änderungen. Das hat das Europäische Patentamt in München entschieden. Die Organisationen «Ärzte ohne Grenzen» und «Ärzte der Welt» scheiterten demnach weitgehend mit ihrem Ve...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Study: Daily aspirin likely won't prolong life

Study: Daily aspirin likely won't prolong life


According to a study partially funded by the National Institutes of Health, a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without previous cardiovascular events showed that aspirin did not prolong healthy living free of dementia or persistent physical disability.



from Biotech News
Share:

Merck & Co., Inc. (MRK) Position Lowered by Rhumbline Advisers

Merck & Co., Inc. (MRK) Position Lowered by Rhumbline Advisers


Rhumbline Advisers lessened its position in shares of Merck & Co., Inc. by 1.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,415,798 shares of the company's stock after selling 52,631 shares during the quarter.



from Biotech News
Share:

Novartis (NVS) Upgraded at ValuEngine

Novartis (NVS) Upgraded at ValuEngine


Other analysts have also recently issued reports about the company. Exane BNP Paribas raised Novartis from an underperform rating to a neutral rating in a research report on Tuesday, September 11th.



from Biotech News
Share:

Louisiana grant will shred old tires that breed mosquitoes

Louisiana grant will shred old tires that breed mosquitoes


A Louisiana parish is getting a $605,000 federal grant to shred old tires that hold standing water and breed mosquitoes that spread disease. Louisiana's health department says it secured the grant from the U.S. Centers for Disease Control and Prevention to give to the East Baton Rouge Parish mosquito control district.



from Biotech News
Share:

Contrasting Tandem Diabetes Care

Contrasting Tandem Diabetes Care


Tandem Diabetes Care and Anika Therapeutics are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk and analyst recommendations. Anika Therapeutics has higher revenue and earnings than Tandem Diabetes Care.



from Biotech News
Share:

Dr Pepper Snapple Group Inc. (DPS) Given Consensus Rating of "Hold" by Analysts

Dr Pepper Snapple Group Inc. (DPS) Given Consensus Rating of "Hold" by Analysts


Shares of Dr Pepper Snapple Group Inc. have been given an average rating of "Hold" by the seventeen brokerages that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, ten have assigned a hold recommendation and six have given a buy recommendation to the company.



from Biotech News
Share:

Fortress Biotech (FBIO) Receives $10.67 Average Price Target from Analysts

Fortress Biotech (FBIO) Receives $10.67 Average Price Target from Analysts


Fortress Biotech has been assigned an average rating of "Buy" from the six ratings firms that are currently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company.



from Biotech News
Share:

Zacks: Brokerages Expect Cellect Biotech/S (Apop) Will Post Earnings of -$0.28 Per Share

Zacks: Brokerages Expect Cellect Biotech/S (Apop) Will Post Earnings of -$0.28 Per Share


Equities analysts expect CELLECT BIOTECH/S to announce earnings per share for the current quarter, Zacks Investment Research reports. Zero analysts have provided estimates for CELLECT BIOTECH/S's earnings.



from Biotech News
Share:

US health regulator approves Teva's migraine drug

US health regulator approves Teva's migraine drug


Israeli drugmaker Teva Pharmaceutical Industries on Friday received approval from the U.S. Food and Drug Administration to sell its new migraine treatment, a key drug the company has been banking on to help revive its fortunes. A man walks past the logo of Teva Pharmaceutical Industries at their plant in Jerusalem December 14, 2017.



from Biotech News
Share:

High blood sugar in pregnancy can have long-term effects

High blood sugar in pregnancy can have long-term effects


New research from the National Institutes of Health indicates that women with elevated blood glucose levels were more likely to develop type 2 diabetes a decade after pregnancy and that their children were significantly more likely to be obese. New research from the National Institutes of Health indicates that women with elevated blood glucose levels were more likely to develop type 2 diabetes a decade after pregnancy and that their children were New research from the National Institutes of Health indicates that women with elevated blood glucose levels were more likely to develop type 2 diabetes a decade after pregnancy and that their children were significantly more likely to be obese.



from Biotech News
Share:

Maryland attorney general seeks $20 million in damages from fentanyl manufacturer accused of scheme

Maryland attorney general seeks $20 million in damages from fentanyl manufacturer accused of scheme


John Kapoor, billionaire founder of Insys Therapeutics, leaves federal court in Boston last year after being arrested on fraud charges stemming from allegations the fim bribed doctors to prescribe a fentanyl spray. Maryland's Attorney General is alleging similar actions.



from Biotech News
Share:

Insider Selling: USANA Health Sciences, Inc. (USNA) Insider Sells 5,838 Shares of Stock

Insider Selling: USANA Health Sciences, Inc. (USNA) Insider Sells 5,838 Shares of Stock


USANA Health Sciences, Inc. insider Kevin Guest sold 5,838 shares of the company's stock in a transaction that occurred on Friday, September 14th. The stock was sold at an average price of $130.08, for a total value of $759,407.04.



from Biotech News
Share:

Billionaire Miami philanthropist Phillip Frost denies fraud charges

Billionaire Miami philanthropist Phillip Frost denies fraud charges


Billionaire Miami philanthropist Phillip Frost is denying allegations by the Securities and Exchange Commission that he committed securities fraud as part of a years-long "pump-and-dump" scheme. In a statement emailed to reporters Friday afternoon, Frost said he was "stunned" by the SEC's civil complaint , filed a week ago.



from Biotech News
Share:

More lawsuits filed against Pasha in food poisoning outbreak

More lawsuits filed against Pasha in food poisoning outbreak


Click through the slideshow for how to clean your refrigerator if you have recalled food, according to the Centers for Disease Control and Prevention. Click through the slideshow for how to clean your refrigerator if you have recalled food, according to the Centers for Disease Control and Prevention.



from Biotech News
Share:

Biotech fields seek veterans for jobs

Biotech fields seek veterans for jobs


San Diego's accelerating biotech industry is stepping up its efforts to attract veterans to apply for its open jobs. On Friday, the industry held a symposium with some of San Diego's key life science companies, such as Illumina, NuVasive, and Neurocrine, on ways to get military members transitioning out of service to become their employees.



from Biotech News
Share:

AstraZeneca's (AZN) "Hold" Rating Reaffirmed at Shore Capital

AstraZeneca's (AZN) "Hold" Rating Reaffirmed at Shore Capital


A number of other equities analysts have also weighed in on AZN. Liberum Capital reiterated a "hold" rating on shares of AstraZeneca in a report on Friday, May 18th.



from Biotech News
Share:

Illumina, Inc. (ILMN) Shares Bought by DF Dent & Co. Inc.

Illumina, Inc. (ILMN) Shares Bought by DF Dent & Co. Inc.


DF Dent & Co. Inc. grew its holdings in Illumina, Inc. by 2.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.



from Biotech News
Share:

Chinese scientist pleads guilty in plot to steal GSK secrets

Chinese scientist pleads guilty in plot to steal GSK secrets


A Chinese scientist has pleaded guilty to conspiring to steal biopharmaceutical trade secrets from GlaxoSmithKline in what prosecutors said was a scheme to set up companies in China to market them. Tao Li pleaded guilty Friday in federal court to a single conspiracy count.



from Biotech News
Share:

Pfizer, Merck and Novartis to shut manufacturing sites as hurricane looms

Pfizer, Merck and Novartis to shut manufacturing sites as hurricane looms


Major pharmaceutical companies and CMOs in the US have announced emergency contingency plans, including facility closures and the relocation of drug products, as Hurricane Florence approaches southeastern shores. A hurricane due to hit southeastern states in the US this week has prompted President Trump to declare a an emergency in the state of North Carolina.



from Biotech News
Share:

The Daily Biotech Pulse: Progenics Posts Mixed Trial Results,...

The Daily Biotech Pulse: Progenics Posts Mixed Trial Results,...


Vital Therapies Inc Progenics Pharmaceuticals, Inc. released top-line data from its Phase 3 trial of 1404, a prostate-specific membrane antigen-targeted small molecule SPECT/CT imaging agent designed to visualize prostate cancer. The study showed that 1404 detected clinically meaningful prostate cancer with specificity ranging among the three readers from 71-75 percent.



from Biotech News
Share:

Study Cracks Open the Secrets of Genetic Mutations That Boost Breast and Ovarian Cancer Risk

Study Cracks Open the Secrets of Genetic Mutations That Boost Breast and Ovarian Cancer Risk


Lawsuits didn't do it, public shaming didn't do it, patients and doctors banding together to "free the data" couldn't do it: For 22 years Myriad Genetics, one of the oldest genetic testing companies, has refused to make public its proprietary database of BRCA1 variants, which lists more than 17,000 known misspellings in that major "cancer risk" gene, along with the medical significance of each. The database lists which mutations increase the risk of breast and ovarian cancer, which do not, and which have an unknown health effect.



from Biotech News
Share:

New means to fight 'un-killable' bacteria in healthcare settings

New means to fight 'un-killable' bacteria in healthcare settings


IMAGE: Dr. Dao Nguyen looking at Pseudomonas aeruginosa that has been listed among the "nightmare bacteria " by the Centers for Disease Control and Prevention in the United States, with an... view September 13 2018, Montreal - Scientists at the Research Institute of the McGill University Health Centre have identified new means of fighting drug-tolerant bacteria, a growing global threat as menacing as drug-resistant microbes. Little is known about the mechanisms leading to tolerance, a strategy that makes bacteria "indifferent" to antibiotics and almost "un-killable," which results in chronic infections extremely difficult to treat and cure.



from Biotech News
Share:

EMBL Ventures Portfolio Company, ViraTherapeutics von Boehringer Ingelheim in Höhe von 210 Mio. EUR übernommen

EMBL Ventures Portfolio Company, ViraTherapeutics von Boehringer Ingelheim in Höhe von 210 Mio. EUR übernommen


EMBL Ventures gab bekannt, dass Boehringer Ingelheim seine Option zum Erwerb des Portfoliounternehmens ViraTherapeutics von EMBL Ventures in einer Transaktion mit einem Gesamtwert von 210 Mio. EUR (245 Mio. USD) ausgeübt hat. Die Akquisition folgt einer Kooperations- und Optionsvereinbarung zwischen...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Finanzen: Arbeitsvertragsrecht : Ratgeber Arbeitsvertrag

Ein Arbeitsvertrag ist wichtig. Er regelt praktisch alles rund um Ihren Job. Auf diese Klauseln sollten Sie besonders achten, bevor Sie unterschreiben.

from Finanztip Feed
Supported by Video Collection
Share:

Organigram invests in firm that can produce cannabis' active ingredients in lab

Organigram invests in firm that can produce cannabis' active ingredients in lab


The parent company of marijuana producer Organigram Inc. has closed a $10-million investment deal with Hyasynth Biologicals, boosting its access to biotechnology that can produce cannabis' active chemical ingredients in a lab without needing a costly grow-op. Organigram says Hyasynth's proprietary technology can produce active ingredients that occur naturally in the cannabis plant, called phytocannabinoids, using genetically engineered strains of yeast in a technique known as biofermentation.



from Biotech News
Share:

Seoul Bio Hub pioneers Korea's vision for successful biotech cluster

Seoul Bio Hub pioneers Korea's vision for successful biotech cluster


Hongneung is a quaint neighborhood in northeastern Seoul, situated near several universities and research institutes. In this area stands an organization working toward an ambitious national goal that goes beyond academia - pioneering a successful biotechnology cluster in South Korea.



from Biotech News
Share:

La Jolla: Former LJCDS teacher arrested for sex crimes with minor

La Jolla: Former LJCDS teacher arrested for sex crimes with minor


SAN DIEGO A former teacher at La Jolla Country Day has been arrested in the Bay Area after being accused of sex crimes with a minor. Sammartino left La Jolla Country Day School in 2016, to teach at two different schools in the Bay Area.



from Biotech News
Share:

Finanzen: VW-Abgas-Skandal - Ihre Rechte als Aktionär : Schadensersatzanspruch für VW-Aktionäre

VW-Aktionäre haben Anspruch auf Schadensersatz wegen des Abgas-Skandals. So können Sie Ihre Rechte im Musterverfahren geltend machen.

from Finanztip Feed
Supported by Video Collection
Share:

BIO Applauds Legislation to Spur Investment in Start-ups

BIO Applauds Legislation to Spur Investment in Start-ups


Sep 12, 2018--The Biotechnology Innovation Organization today applauded the introduction of the American Innovation Act of 2018 , which includes a provision that would protect investments in start-ups from inadvertently triggering the net operating loss limitations under Section 382 of the tax code. R&D-intensive biotech start-ups frequently accumulate substantial NOLs in their early, pre-revenue years, given their typical reliance on investor capital for more than a decade before realizing any product revenue.



from Biotech News
Share:

Finanzen: Nachtspeicherheizung : Nachtspeicherheizung

Mit günstigem Nachtstrom lässt sich viel Geld sparen.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Wärmepumpen : Wärmepumpe

Für elektrische Wärmepumpen gibt es spezielle Stromtarife. Sie sind rund 30 Prozent günstiger als Haushaltsstrom.

from Finanztip Feed
Supported by Video Collection
Share:

Takeda to pack up Illinois HQ, nearly 1,000 workers to be affected

Takeda to pack up Illinois HQ, nearly 1,000 workers to be affected


Japan's Takeda Pharmaceutical Co Ltd said on Wednesday it plans to shut its U.S. headquarters in Deerfield, Illinois and move it to the greater Boston area, following the closing of its Shire Plc acquisition. Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo, Japan, July 2, 2018.



from Biotech News
Share:

Finanzen: Stromzähler : Stromzähler

Verbraucher bekommen in den nächsten Jahren digitale Stromzähler oder intelligente Messsysteme installiert. Das schreibt das Messstellenbetriebsgesetz vor. Für Haushalte bedeutet das höhere Kosten von bis zu 100 Euro pro Jahr.

from Finanztip Feed
Supported by Video Collection
Share:

City's biotechnology investment pays off

City's biotechnology investment pays off


Promoting biotechnology is proving beneficial for both South San Francisco and the county as the industry generated 45,000 jobs while adding $2.285 billion every year in local salaries. Taking a closer look at biotechnology in South San Francisco helped the City Council see the growth and also plans for the future.



from Biotech News
Share:

Biotech IPOs are booming, but is the frenzy almost over?

Biotech IPOs are booming, but is the frenzy almost over?


Biotechnology companies have been going public at a blistering pace this year, even as private investors are pouring more and more money into younger and younger startups. Through Friday, there were 38 new listings by biotech companies this year, raising almost $3.9 billion, the most since a wave of upstart drugmakers went public in 2000, stirred by excitement over an early generation of genetic therapies.



from Biotech News
Share:

Lab test may identify dangerous gene mutations, study finds

Lab test may identify dangerous gene mutations, study finds


This undated fluorescence-colored microscope image made available by the National Institutes of Health in September 2016 shows a culture of human breast cancer cells. On Wednesday, Sept.



from Biotech News
Share:

Regeneron plans to add 1,500 in East Greenbush

Regeneron plans to add 1,500 in East Greenbush


Registration will allow you to post comments on timesunion.com and create a timesunion.com Subscriber Portal account for you to manage subscriptions and email preferences. Sign outside of Regeneron Pharmaceuticals on Tuesday, Aug. 6, 2013 in East Greenbush, N.Y. The drug they make called Eylea has been highly successful so they are expanding.



from Biotech News
Share:

Finanzen: Probezeit im Arbeitsrecht : Probezeit im Arbeitsrecht

Jeder neue Job beginnt mit einer Probezeit. Der Arbeitgeber darf dem Einsteiger in dieser Phase ohne Angabe von Gründen kündigen. An bestimmte Kündigungsfristen müssen sich beide Seiten aber trotzdem halten.

from Finanztip Feed
Supported by Video Collection
Share:

Global Biologics Manufacturing Market 2018-2022 - Rise in Partnerships Between Traditional Biopharma Companies and Biotechnology Startups - ResearchAndMarkets.com

Global Biologics Manufacturing Market 2018-2022 - Rise in Partnerships Between Traditional Biopharma Companies and Biotechnology Startups - ResearchAndMarkets.com


Global Biologics Manufacturing Market 2018-2022 has been prepared based on an in-depth market analysis with inputs from industry experts. The report also includes a discussion of the Key vendors operating in this market.



from Biotech News
Share:

Eggs sold in Alabama, Georgia, Tennessee recalled over salmonella concerns

Eggs sold in Alabama, Georgia, Tennessee recalled over salmonella concerns


ATLANTA An Alabama farm has recalled its eggs after the Centers for Disease Control and Prevention linked them to a multi-state salmonella outbreak. On Sept.



from Biotech News
Share:

Startups – bessere Einstellungschancen, aber weniger Gehalt für benachteiligte Arbeitnehmer

Startups – bessere Einstellungschancen, aber weniger Gehalt für benachteiligte Arbeitnehmer


image description
Ältere Arbeitnehmer, Menschen fremder Nationalität, Opfer einer Betriebsschließung, Langzeitarbeitslose oder weniger qualifizierte Bewerber: Sie alle haben schlechte Chancen auf dem Arbeitsmarkt, jedoch nicht bei Startup-Unternehmen. Das haben Forscher der FAU, des Leibniz-Instituts für Wirtschaftsf...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Should One-A-Day Be Once-A-Day?

Should One-A-Day Be Once-A-Day?


Miles Laboratories pioneered the concept of daily dosing of multivitamins and minerals in the 1940s with the introduction of its One A Day brand. Now owned by Bayer AG, the brand encompasses a suite of vitamins for targeted at men, women and children.



from Biotech News
Share:

4 honored for genetic research and developing anesthetic

4 honored for genetic research and developing anesthetic


This 2012 photo provided by the Albert and Mary Lasker Foundation shows Dr. Joan Steitz in her lab in New Haven, Conn. On Tuesday, Sept.



from Biotech News
Share:

Do lots of ticks mean lots of Lyme? Maybe not

Do lots of ticks mean lots of Lyme? Maybe not


This undated file photo provided by the U.S. Centers for Disease Control and Prevention shows a blacklegged tick, also known as a deer tick, a carrier of Lyme disease. Preliminary indicators show Lyme disease abating during the summer of 2018 in New England, and public health authorities said they are finding fewer ticks in the environment.



from Biotech News
Share:

Finanzen: iPhone günstig kaufen : iPhone kaufen

Apple verlangt für manche iPhone-Modelle vierstellige Beträge. Doch so viel Geld müssen Sie nicht ausgeben. Es gibt Wege, günstiger an ein iPhone zu kommen.

from Finanztip Feed
Supported by Video Collection
Share:

Chronic pain may contribute to suicide, study warns

Chronic pain may contribute to suicide, study warns


Nearly one in 10 suicide deaths in the U.S. occurs in people with chronic pain, a new study indicates. While the study can't prove that chronic pain contributed to people's decisions to kill themselves, "we did see that mental health issues, such as depression and anxiety were more common among those with chronic pain," said lead author Dr. Emiko Petrosky, a medical epidemiologist with the U.S. Centers for Disease Control and Prevention in Atlanta.



from Biotech News
Share:

Zahlreiche Gentherapien kurz vor der Marktreife

Zahlreiche Gentherapien kurz vor der Marktreife


image description
Die Zahl genetischer Therapien wird in den kommenden Jahren stark zunehmen. Viele dieser Gentherapien zeichnen sich durch eine Langwirksamkeit aus. Derzeit sind drei langwirksame Gentherapien in der EU zugelassen. 42 weitere stehen kurz vor der Marktreife, da sie sich in späten Phasen der klinischen...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Sartorius lässt sich mit weiteren Zukäufen Zeit

Sartorius lässt sich mit weiteren Zukäufen Zeit


(dpa-AFX) Nach einer regen Übernahmetätigkeit muss der Pharma- und Laborzulieferer Sartorius nun das Tempo seiner Zukäufe drosseln. Die zuletzt stark gestiegenen Bewertungen von Technologiefirmen erschweren derzeit die Einkaufstour des künftigen MDax-Mitglieds. "Wir schauen uns um und werden auch ak...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Ladenburg chairman charged with fraud by SEC in penny stock scheme

Ladenburg chairman charged with fraud by SEC in penny stock scheme


Dr. Phillip Frost was among 10 individuals named in a lawsuit for participating in long-running schemes that generated over $27 million from unlawful stock sales and left investors holding virtually worthless stock, the SEC claims Dr. Phillip Frost, the non-executive chairman and largest shareholder of Ladenburg Thalmann Financial Services Inc. has been charged with fraud by the Securities and Exchange Commission for his involvement in a pump-and-dump, penny stock scheme.



from Biotech News
Share:

Oncolytics Biotech Collaborates with SOLTI to Conduct a Window of...

Oncolytics Biotech Collaborates with SOLTI to Conduct a Window of...


Oncolytics Biotech Inc. , currently developing REOLYSIN , an intravenously delivered immuno-oncolytic virus turning cold tumors hot, today announced a clinical collaboration with SOLTI, an academic research group dedicated to clinical and translational research in breast cancer. This clinical collaboration, being sponsored by Oncolytics and facilitated by SOLTI, is a window of opportunity study in the neoadjuvant setting for breast cancer.



from Biotech News
Share:

UK Stocks-Factors to watch on Sept 10

UK Stocks-Factors to watch on Sept 10


Sept 10 - Britain's FTSE 100 index is seen opening up 19 points at 7,297 points on Monday, according to financial bookmakers. * GSK: GlaxoSmithKline said on Friday that U.S. health authorities had asked for more information about its Nucala drug for use in combating chronic obstructive pulmonary disease .



from Biotech News
Share:

Taiwan biotech can take off by overcoming challenges, says Frank Kung, founder of Vivo Capital

Taiwan biotech can take off by overcoming challenges, says Frank Kung, founder of Vivo Capital


Having started three businesses, two of which successfully went public, founder of Vivo Capital Frank Kung set foot in the biotech sector in the 1970s. Thanks to Kung's decades of experiences in investing in biotech firms in the US and Greater China, Vivo Capital has made itself the largest biotech venture capital fund in Chinese communities worldwide, managing over US$1.7 billion in capital including the Taiwan Silicon Valley Technology Fund.



from Biotech News
Share:

Tocqueville Asset Management L.P. Grows Position in McKesson Co.

Tocqueville Asset Management L.P. Grows Position in McKesson Co.


Tocqueville Asset Management L.P. increased its holdings in shares of McKesson Co. by 11.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission.



from Biotech News
Share:

Top breast cancer researcher busted for failure to disclose extensive ...

Top breast cancer researcher busted for failure to disclose extensive ...


One of the world's top breast cancer doctors failed to disclose millions of dollars in payments from drug and health care companies in recent years, omitting his financial ties from dozens of research articles in prestigious publications like The New England Journal of Medicine and the Lancet. The researcher, Dr. JosA© Baselga, a towering figure in the cancer world, is the chief medical officer at Memorial Sloan Kettering Cancer Center in New York.



from Biotech News
Share:

Sartorius will in Göttingen viele neue Stellen schaffen

Sartorius will in Göttingen viele neue Stellen schaffen


(dpa-AFX) Göttingens größter privater Arbeitgeber, Pharma- und Laborausrüster Sartorius, will die Zahl der Stellen in den kommenden Jahren deutlich steigern. Statt derzeit rund 2800 Mitarbeiter werde die Sartorius AG im Jahr 2025 etwa 3500 bis 4000 Menschen in der Universitätsstadt beschäftigen, sag...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Biotech program at MCC is Platinum

Biotech program at MCC is Platinum


Middlesex Community College's Biotechnology Technician degree and certificate programs have received a Platinum endorsement -- the highest rating -- from the Massachusetts Biotechnology Education Foundation's 2017 Biotechnology Endorsement Program. "This endorsement from the Massachusetts Biotechnology Education Foundation is certainly an honor," Middlesex President James C. Mabry said.



from Biotech News
Share:

AstraZeneca plc (AZN) Expected to Post Earnings of $0.44 Per Share

AstraZeneca plc (AZN) Expected to Post Earnings of $0.44 Per Share


Equities analysts expect AstraZeneca plc to post $0.44 earnings per share for the current quarter, according to Zacks Investment Research . Zero analysts have made estimates for AstraZeneca's earnings, with the highest EPS estimate coming in at $0.46 and the lowest estimate coming in at $0.42.



from Biotech News
Share:

Cellect Biotech/S (Apop) Given Consensus Rating of "Strong Buy" by Brokerages

Cellect Biotech/S (Apop) Given Consensus Rating of "Strong Buy" by Brokerages


Shares of CELLECT BIOTECH/S have been given a consensus broker rating score of 1.00 from the one analysts that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy rating.



from Biotech News
Share:

Hot, dry summer bringing fewer cases of Lyme disease

Hot, dry summer bringing fewer cases of Lyme disease


This undated file photo provided by the U.S. Centers for Disease Control and Prevention shows a blacklegged tick, also known as a deer tick, a carrier of Lyme disease. Preliminary indicators show Lyme disease abating during the summer of 2018 in New England, and public health authorities said they are finding fewer ticks in the environment.



from Biotech News
Share:

NumerixS Investment Technologies Inc Has $1.63 Million Holdings in Amgen, Inc.

NumerixS Investment Technologies Inc Has $1.63 Million Holdings in Amgen, Inc.


NumerixS Investment Technologies Inc decreased its position in shares of Amgen, Inc. by 8.0% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,910 shares of the medical research company's stock after selling 779 shares during the period.



from Biotech News
Share:

Ex-Teva Chairman Accused of Pump-and-Dump Scheme

Ex-Teva Chairman Accused of Pump-and-Dump Scheme


A former chairman of Teva Pharmaceutical Industries Ltd. and an investor known for benefiting from the hype around cryptocurrencies were sued by regulators on Friday over claims they masterminded a pump-and-dump scheme. The Securities and Exchange Commission alleged that Phillip Frost and Barry Honig, along with eight other individuals, conspired to manipulate the price of several small stocks so they could later sell their shares at inflated prices.



from Biotech News
Share:

Company got Indianapolis tax break despite pending appeals

Company got Indianapolis tax break despite pending appeals


A published report says Indianapolis officials approved a $9.3 million tax break for drug maker Eli Lilly and Co.



from Biotech News
Share:

Bayer officials vague on lawsuit strategy, despite liability

Bayer officials vague on lawsuit strategy, despite liability


It's been nearly three weeks since the merger between Bayer AG and Monsanto officially began its integration, about two months since the deal closed and nearly two years since the planned deal was announced. Despite that, newly appointed Bayer officials are vague on how they plan to handle the mountain of lawsuits inherited from Monsanto over pesticides such as glyphosate and dicamba.



from Biotech News
Share:

Opko Health, PolarityTE Under Fire From SEC; Mark Cuban Confirms He's Short The Stocks

Opko Health, PolarityTE Under Fire From SEC; Mark Cuban Confirms He's Short The Stocks


Billionaire investor and "Shark Tank" personality Mark Cuban confirmed to Benzinga Friday afternoon that he's short both Opko Health and PolarityTE. Cuban was recently questioned about his shorts on CNBC and refused to answer, and said: "If you want to know where my short interests traditionally have been, just check out that site, because we publish it all.



from Biotech News
Share:

Two health scares at U.S. airports tied to Mecca pilgrims: U.S. officials

Two health scares at U.S. airports tied to Mecca pilgrims: U.S. officials


Two major health scares at U.S. airports involving inbound flights are related to pilgrims returning from the Hajj, the Muslim pilgrimage to the holy city of Mecca, Saudi Arabia, which ended in late August, U.S. health officials said on Friday. FILE PHOTO: The emergency services are seen, after the passengers were taken ill on a flight from New York to Dubai, on JFK Airport, New York, U.S., September 05, 2018 in this still image obtained from social media.



from Biotech News
Share:

Miami billionaire, museum donor named in stock scheme

Miami billionaire, museum donor named in stock scheme


A Miami biotech billionaire with his name on the city's science museum has been charged in a market-manipulation scheme. The Securities and Exchange Commission announced Friday that OPKO Health founder and CEO Phillip Frost and nine others participated in long-running fraudulent schemes that generated more than $27 million from unlawful stock sales and caused significant harm to retail investors who were left holding virtually worthless stock.



from Biotech News
Share:

Johnson & Johnson (JNJ) Holdings Reduced by Guggenheim Capital LLC

Johnson & Johnson (JNJ) Holdings Reduced by Guggenheim Capital LLC


Guggenheim Capital LLC lowered its stake in Johnson & Johnson by 2.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission . The fund owned 1,058,389 shares of the company's stock after selling 30,568 shares during the quarter.



from Biotech News
Share:

Hologic, Inc. (HOLX) Shares Sold by Earnest Partners LLC

Hologic, Inc. (HOLX) Shares Sold by Earnest Partners LLC


Earnest Partners LLC lowered its stake in shares of Hologic, Inc. by 3.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 175,060 shares of the medical equipment provider's stock after selling 6,152 shares during the period.



from Biotech News
Share:

Luxury Magazine Unveils Its Fall 2018 Issue: Style & Design

Luxury Magazine Unveils Its Fall 2018 Issue: Style & Design


The Ultimate Road Trip This issue takes readers on the drive of a lifetime along Highway 10, more commonly known as the Inuvik-Tuktoyaktuk Highway. Explore this unique coastal community on the Arctic Ocean cruising through 85 miles-to the top of the world-of spectacular scenery featuring iridescent lakes, lush forests and plenty of wildlife.



from Biotech News
Share:

Oncolytics Biotech (ONCY) Receiving Somewhat Favorable News Coverage, Study Shows

Oncolytics Biotech (ONCY) Receiving Somewhat Favorable News Coverage, Study Shows


Media headlines about Oncolytics Biotech have been trending somewhat positive this week, according to Accern. Accern rates the sentiment of media coverage by monitoring more than twenty million news and blog sources.



from Biotech News
Share:

Finanzen: LTE : LTE

LTE macht das Surfen unterwegs und zu Hause schneller. Doch nicht jeder kann den schnellen Datenfunk sofort nutzen.

from Finanztip Feed
Supported by Video Collection
Share:

40 and under: The Silicon Valley biotech stars who are backing...

40 and under: The Silicon Valley biotech stars who are backing...


Putting millions of dollars into bold new technologies can be a delicate business when lives hang in the balance. But every day some of the sharpest minds in Silicon Valley make big bets on tools and techniques that promise to cure disease, help fix the food system, and even prolong life.



from Biotech News
Share:

Silicon Valley's top biotech investors reveal what the crash and...

Silicon Valley's top biotech investors reveal what the crash and...


Theranos, a blood-testing startup that claimed it would revolutionize healthcare by doing away with "big bad needles," crashed and burned after it was revealed that it lacked concrete science. But biotech startups remain hot in Silicon Valley , with nearly a third of the companies from startup hub Y Combinator's latest class falling into the category.



from Biotech News
Share:

Neuer Vorstandsvorsitzender bei Gerresheimer

Neuer Vorstandsvorsitzender bei Gerresheimer


image description
Dietmar Siemssen (55) wird am 01. November 2018 den Vorstandsvorsitz der Gerresheimer AG übernehmen. Das hat der Aufsichtsrat der Gerresheimer AG in seiner Sitzung beschlossen. Dietmar Siemssen war von 2011 bis Juli 2018 CEO von Stabilus und zuvor 19 Jahre bei Continental in verschiedenen Senior-Man...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Novartis erhält auch in Kanada Zulassung für Gentherapie

Novartis erhält auch in Kanada Zulassung für Gentherapie


(awp) Novartis hat nach der Zulassung seiner Gentherapie Kymriah in der EU nun auch in Kanada eine entsprechende Erlaubnis erhalten. Kymriah wurde in Kanada für die Behandlung von zwei Krebsarten zugelassen, wie der Konzern am Donnerstag in Basel mitteilte. Kymriah ist für den Einsatz bei Patienten ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Maryland charges Insys with engaging in deceptive opioid scheme

Maryland charges Insys with engaging in deceptive opioid scheme


Maryland on Thursday charged Insys Therapeutics Inc with deceptively marketing a powerful opioid pain killer so that it was prescribed inappropriately beyond its intended use with cancer patients. FILE PHOTO: A box of the Fentanyl-based drug Subsys, made by Insys Therapeutics Inc, is seen in an undated photograph provided by the U.S. Attorney's Office for the Southern District of Alabama.



from Biotech News
Share:

Finanzen: Bausparvertrag : Bausparvertrag Vergleich

Ein Bausparvertrag kombiniert Immobiliendarlehen und Banksparplan. Sie können sich lange im Voraus niedrige Zinsen sichern. Doch es gibt Fallstricke.

from Finanztip Feed
Supported by Video Collection
Share:

GlaxoSmithKline to cut 650 US jobs, reinvest in R & D

GlaxoSmithKline to cut 650 US jobs, reinvest in R & D


The News & Observer reports the United Kingdom-based company notified the North Carolina Department of Commerce on Wednesday that it will cut 100 jobs at its Research Triangle Park office, and 450 field sales jobs across the country. GlaxoSmithKline is also cutting 100 positions at its Philadelphia office.



from Biotech News
Share:

Government knew of Johnson & Johnson faulty hip implants, took almost two years to ban

Government knew of Johnson & Johnson faulty hip implants, took almost two years to ban


GLOBALLY, Johnson & Johnson recalled its faulty hip implant on August 24, 2010 but it took Indian regulators almost two years to ban its import and cancel its licence, official records obtained by The Indian Express reveal. This despite the fact that the regulator, Central Drugs Standard Control Organisation, which comes under the Ministry of Health and Family Welfare, was informed of the global recall in 2010 itself.



from Biotech News
Share:

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings


The links to ... )--Amundi Pioneer Asset Management today announced the declaration of dividends for five Pioneer closed-end funds for September.



from Biotech News
Share:

NIH: Disability as common with chronic pain as with some other...

NIH: Disability as common with chronic pain as with some other...


About 11 million adults nationwide have high-impact chronic pain - characterized by pain lasting for three months or longer, and resulting in at least one major activity restriction. And a new study by the National Institutes of Health shows that disability is as likely for those who have suffered chronic pain as it is for patients of kidney failure, emphysema or stroke.



from Biotech News
Share:

Finanzen: Internet-Flat : Internet-Flat

Bei der Fülle an Internetanbietern kann man leicht den Überblick verlieren. Finanztip hat die besten DSL- und Kabeltarife verglichen und die günstigsten Internet-Flats zusammengestellt, damit Sie nicht suchen müssen. Außerdem erfahren Sie die wichtigsten Tipps zum Thema Internet-Flatrate.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Internetanbieter : Internetanbieter-Vergleich

Internet gehört fast so selbstverständlich zum Haushalt wie Wasser und Strom. Doch in der Fülle der Internetanbieter lässt sich schnell der Überblick verlieren. Finanztip hat die besten Internetanbieter verglichen, damit Sie schnell und einfach den günstigsten Internettarif finden.

from Finanztip Feed
Supported by V